Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast ...
Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular carcinoma, ovarian cancer and lung adenocarcinoma ...
News Medical on MSN13d
New procedure standard/practice guideline issued for fibroblast activation protein PETThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have ...
After missing the primary endpoint in the Phase IIb SYMMETRY trial, Akero Therapeutics’ lead molecule, efruxifermin, showed ...
Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...
Insilico Medicine (“Insilico”) announces that the team, with the support of its generative chemistry engine, has developed a ...
Women's Health on MSN13d
All The Ways Light Affects Your Skin, According To Dermatologists And ScienceThe point is that we generally consider light to be good, safe, even comforting. Yet when it comes to our skin, things are a ...
News Medical on MSN10d
Unlocking the potential of receptor-based approaches in diabetes treatmentAnnouncing a new article publication for BIO Integration journal. Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...
Zika, a mosquito-borne virus first identified in 1947 in a Rhesus macaque monkey, continues to perplex scientists in many ways nearly 80 years later. While many people with a Zika virus infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback